The metallic nickel nanoparticle is a product with many new characteristics, which include a high level of surface energy, high magnetism, low melting point, high surface area, and low burning point. Therefore, it can be widely used in modern industries. However, metallic nickel nanoparticles may also initiate adverse health effects. Numerous studies have described the pathogenic and carcinogenic effects of nickel compounds, but little has been documented on the biological effects of metallic nickel nanoparticles. Activator protein-1 (AP-1) and nuclear factor-kB (NF-kB) have been shown to play pivotal roles in tumor initiation, promotion, and progression. The present study examines effects of metallic nickel particles on tumor promoter or suppressor genes and its signal transduction pathways in JB6 cells. Our results demonstrated that metallic nickel nanoparticles activated AP-1 and NF-kB more efficiently than nickel fine particles as investigated using luciferase assay, western blot, as well as immunocytochemistry staining. Further studies indicated that, compared to fine particles, nickel nanoparticles induced a higher level protein expression of c-myc and R-Ras in a time-dependent manner. Furthermore, nickel nanoparticles caused a greater decrease of p53 transcription activity than fine particles as demonstrated by luciferase assay. These findings suggest that nickel nanoparticles may exhibit higher carcinogenic potential than nickel fine particles. The results obtained from this study will be of benefit for elucidating the pathogenic and carcinogenic potential of metallic nickel nano- and fine particles. In addition, the results may be useful as a reference when comparing the carcinogenesis of different nickel compounds.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.